These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 600086)
1. [Antitumor antibiotics produced by Actinomycetes]. Gauze GF Mikrobiologiia; 1977; 46(5):821-7. PubMed ID: 600086 [No Abstract] [Full Text] [Related]
2. Application of mutation of T2 phage from h+ to h to screening of antitumor antibiotics produced by actinomycetes. Nakamura S; Omura S; Hamada M; Nishimura T; Yamaki H J Antibiot (Tokyo); 1967 Jul; 20(4):217-22. PubMed ID: 6072896 [No Abstract] [Full Text] [Related]
3. A search for antitumor substances in the fermentation broths of actinomycetes active against antibiotic-resistant staphylococci. Ukleja-Bortkiewicz A; Tyc M; Abgarowicz G; Terlecka J Arch Immunol Ther Exp (Warsz); 1967; 15(5):760-4. PubMed ID: 5595077 [No Abstract] [Full Text] [Related]
4. [High molecular weight antineoplastic antibiotics of a polypeptide or protein nature formed by Actinomycetes]. Kuimova TF Antibiotiki; 1966 Jul; 11(7):651-6. PubMed ID: 5997589 [No Abstract] [Full Text] [Related]
5. [Act. olivovariabilis sp.nov., an organism producing variamycin, a new antitumor antibiotic]. Rudaia SM; Singal EM; Il'inskaia SA; Solov'eva NK Antibiotiki; 1971 Nov; 16(11):969-76. PubMed ID: 4947970 [No Abstract] [Full Text] [Related]
11. [Conditions for the formation of the antibiotic rubomycin by the culture Actinomyces coeruleorubidus]. Manafova NA Antibiotiki; 1966 Oct; 11(10):872-7. PubMed ID: 6011841 [No Abstract] [Full Text] [Related]
12. [Role of N-acetyl-4-methyl-3-hydroxyanthranilic acid in biosynthesis of the actinomycin-like antibiotic aurantin]. Orlova TI; Nefelova MV; Kulida LI; Silaev AB Biokhimiia; 1970; 35(4):648-51. PubMed ID: 4100245 [No Abstract] [Full Text] [Related]
13. [Systematic position, variability and antibiotic properties of the producer of the antineoplastic antibiotic rubomycin]. Preobrazhenskaia TP; Manafova NA; Gauze GF Antibiotiki; 1966 Oct; 11(10):867-72. PubMed ID: 5997590 [No Abstract] [Full Text] [Related]
14. UCE6, a new antitumor antibiotic with topoisomerase I-mediated DNA cleavage activity produced by actinomycetes: producing organism, fermentation, isolation and biological activity. Fujii N; Tanaka F; Yamashita Y; Ashizawa T; Chiba S; Nakano H J Antibiot (Tokyo); 1997 Jun; 50(6):490-5. PubMed ID: 9268005 [TBL] [Abstract][Full Text] [Related]
15. [Achievement of C 14 -olivomycin by means of biosynthesis from C 14 -glucose]. Vatin AE; Karpov VL Antibiotiki; 1971 Feb; 16(2):99-103. PubMed ID: 4997524 [No Abstract] [Full Text] [Related]
17. [Use of different methods for the primary selection of antitumor antibiotics]. Ivanitskaia LP; Upiter GD Antibiotiki; 1967 May; 12(5):369-74. PubMed ID: 5627678 [No Abstract] [Full Text] [Related]
18. [Antineoplastic antibiotic 4418 related to the antibiotics of the group pluramyciniomycin]. Kudinova MK; Babenko GA; Ukholina RS; Maksimova TS; Nechaeva NP; Terekhova LP; Rossolimo OK Antibiotiki; 1968 Mar; 13(3):201-5. PubMed ID: 5672120 [No Abstract] [Full Text] [Related]
19. [Carbon and tritium-labeled bruneomycin obtained by biosynthetic method]. Karpov VL; Romanova LG Antibiotiki; 1972 May; 17(5):419-24. PubMed ID: 5032046 [No Abstract] [Full Text] [Related]
20. [Effectiveness of the use of Staphylococcus aureus 209 mutant UV-2 at different stages of screening of new antineoplastic antibiotics]. Kochetkova GV; Il'chenko GB; Kovsharova IN Antibiotiki; 1970 Jul; 15(7):587-90. PubMed ID: 4097990 [No Abstract] [Full Text] [Related] [Next] [New Search]